Efficacy and Safety of Lumiracoxib 400 mg Once Daily in Acute Flares of Gout
NCT00170781
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
234
Enrollment
INDUSTRY
Sponsor class
Conditions
Acute Gouty Arthritis
Interventions
DRUG:
Lumiracoxib
Sponsor
Novartis